{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:45Z","timestamp":1786118805378,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/cad.0b013e328082558a","type":"journal-article","created":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T03:01:26Z","timestamp":1186023686000},"page":"713-719","source":"Crossref","is-referenced-by-count":8,"title":["A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer"],"prefix":"10.1097","volume":"18","author":[{"given":"Carmelo G.","family":"Giorgio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Di Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Castorina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Marletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bellissima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuccio","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetto","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bordonaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","article-title":"Cancer statistics, 1999","volume":"49","author":"Landis","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","article-title":"Participation of patients 65 years of age or older in cancer clinical trials","volume":"21","author":"Lewis","year":"2003","journal-title":"J Clin Oncol"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2004.02.175","article-title":"Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration","volume":"22","author":"Talarico","year":"2004","journal-title":"J Clin Oncol"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z","article-title":"Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group","volume":"59","author":"Perez","year":"1987","journal-title":"Cancer"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/88.17.1210","article-title":"Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial","volume":"88","author":"Dillman","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"R6-13-20210203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jnci\/87.3.198","article-title":"Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer","volume":"87","author":"Sause","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"(Suppl 1)","key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1016\/0169-5002(94)91687-X","article-title":"Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma","volume":"10","author":"Le Chevalier","year":"1994","journal-title":"Lung Cancer"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lungcan.2004.03.004","article-title":"Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study","volume":"46","author":"Zatloukal","year":"2004","journal-title":"Lung Cancer"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.cco.0000155047.51919.0f","article-title":"Treatment of locally advanced non-small cell lung cancer in the elderly","volume":"17","author":"Gridelli","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer (Phila)"},{"key":"R13-13-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Controlled Clin Trials"},{"key":"R14-13-20210203","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1046\/j.1532-5415.2001.49281.x","article-title":"The vulnerable elders survey: a tool for identifying vulnerable older people in the community","volume":"49","author":"Saliba","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"R16-13-20210203","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method for of classifying prognostic comorbidity in longitudinal series. Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronics Dis"},{"key":"R17-13-20210203","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","article-title":"Carboplatin dosage: prospective evaluation of a simple formula based on renal function","volume":"7","author":"Calvert","year":"1989","journal-title":"J Clin Oncol"},{"key":"R18-13-20210203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"R19-13-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0360-3016(01)01858-2","article-title":"Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)","volume":"51","author":"Graham","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-13-20210203","article-title":"Common toxicity criteria (CTC). Version 2.0","year":"1999"},{"key":"R21-13-20210203","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-etienne d'Oncologie Thoracique\u2013Groupe Francais de Pneumo-Canc\u00e9rologie NPC 95 study","volume":"23","author":"Fournel","year":"2005","journal-title":"J Clin Oncol"},{"key":"R24-13-20210203","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1200\/JCO.2005.55.405","article-title":"Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol","volume":"23","author":"Belani","year":"2005","journal-title":"J Clin Oncol"},{"key":"R25-13-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-5002(00)00219-1","article-title":"High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer","volume":"32","author":"Hayakawa","year":"2001","journal-title":"Lung Cancer"},{"key":"R26-13-20210203","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.1998.16.9.3078","article-title":"Southwest oncology group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer","volume":"16","author":"Lau","year":"1998","journal-title":"J Clin Oncol"},{"key":"R27-13-20210203","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0360-3016(98)00283-1","article-title":"Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study","volume":"42","author":"Jeremic","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R28-13-20210203","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"N Engl J Med"},{"key":"R29-13-20210203","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/JCO.1999.17.1.4","article-title":"Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group","volume":"17","author":"Clamon","year":"1999","journal-title":"J Clin Oncol"},{"key":"R30-13-20210203","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1200\/JCO.2003.12.019","article-title":"The outcome of combined-modality therapy for stage III non-small cell lung cancer in the elderly","volume":"21","author":"Schild","year":"2003","journal-title":"J Clin Oncol"},{"key":"R31-13-20210203","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0360-3016(00)00801-4","article-title":"Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival","volume":"48","author":"Werner-Wasik","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R32-13-20210203","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0360-3016(99)00325-9","article-title":"The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) chemoradiation studies","volume":"45","author":"Movsas","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-13-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/cncr.10174","article-title":"Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B","volume":"94","author":"Rocha Lima","year":"2002","journal-title":"Cancer"},{"key":"R35-13-20210203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdj117","article-title":"Concomitant radio-chemotherapy based on platinum compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients","volume":"17","author":"Auperin","year":"2006","journal-title":"Ann Oncol"},{"key":"R36-13-20210203","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijrobp.2006.04.022","article-title":"Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy","volume":"66","author":"Wei","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R37-13-20210203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2006.05.024","article-title":"Is trimodality approach better than bimodality in stage IIIA, N2 positive non-small cell lung cancer?","volume":"53","author":"Park","year":"2006","journal-title":"Lung Cancer"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e328082558a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:49:20Z","timestamp":1786034960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200707000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e328082558a","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}